创新医疗
(002173)
| 流通市值：35.28亿 | | | 总市值：37.36亿 |
| 流通股本：4.24亿 | | | 总股本：4.49亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 543,823,060.69 | 563,083,485.71 | 620,884,321.32 | 603,135,708.97 |
| 应收票据及应收账款 | 123,869,681.86 | 102,840,031.95 | 83,753,870.16 | 70,474,447.14 |
| 应收账款 | 123,869,681.86 | 102,840,031.95 | 83,753,870.16 | 70,474,447.14 |
| 预付款项 | 3,678,319.44 | 2,600,012.09 | 4,755,916.05 | 7,039,474.55 |
| 其他应收款合计 | 1,770,526.33 | 1,531,958.32 | 4,851,736.34 | 3,281,490.67 |
| 存货 | 37,726,419.22 | 41,805,047.04 | 39,910,144.03 | 38,146,287.77 |
| 其他流动资产 | 1,954,498.63 | 1,122,638.28 | 2,426,977.2 | 2,590,546.84 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 733,496,501.97 | 733,059,385.69 | 756,582,965.1 | 724,667,955.94 |
| 非流动资产: | | | | |
| 长期股权投资 | 14,345,628.32 | 15,219,218.88 | 16,159,514.94 | 16,753,193.26 |
| 固定资产 | 1,292,246,152.33 | 1,310,116,701.82 | 1,183,041,217.74 | 1,198,090,007.18 |
| 在建工程 | 6,613,671.99 | 5,945,341.99 | 132,152,701.24 | 122,724,956.49 |
| 使用权资产 | 31,719,776.92 | 33,752,293.3 | 28,680,577.95 | 27,196,706.24 |
| 无形资产 | 132,548,741.03 | 129,557,828.85 | 119,779,787.02 | 120,633,559.52 |
| 商誉 | 986,746.86 | 986,746.86 | 986,746.86 | 986,746.86 |
| 长期待摊费用 | 33,148,622.33 | 34,046,218.38 | 35,734,978.24 | 37,034,853.09 |
| 递延所得税资产 | 17,399,056.11 | 17,009,565.54 | 12,597,293.39 | 12,964,177.51 |
| 其他非流动资产 | 1,779,471.22 | 1,779,471.22 | 5,235,625.54 | 686,671.22 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,530,787,867.11 | 1,548,413,386.84 | 1,534,368,442.92 | 1,537,070,871.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,264,284,369.08 | 2,281,472,772.53 | 2,290,951,408.02 | 2,261,738,827.31 |
| 流动负债: | | | | |
| 短期借款 | 43,170,500 | 30,170,500 | 30,000,000 | - |
| 应付票据及应付账款 | 201,966,108.62 | 208,122,774.97 | 177,645,084.07 | 178,430,724.59 |
| 应付账款 | 201,966,108.62 | 208,122,774.97 | 177,645,084.07 | 178,430,724.59 |
| 预收款项 | 103,333.34 | 47,191.64 | 29,256,558.15 | 29,250,558.15 |
| 合同负债 | 3,558,620.35 | 3,521,976.69 | 5,845,937.93 | 5,685,444.61 |
| 应付职工薪酬 | 31,415,084.1 | 46,033,213.11 | 39,433,907.94 | 33,855,661.45 |
| 应交税费 | 2,496,069.65 | 6,573,408.57 | 5,163,132.12 | 3,844,919.65 |
| 其他应付款合计 | 13,791,909.94 | 12,911,543.12 | 16,144,577.62 | 15,389,639.75 |
| 一年内到期的非流动负债 | 17,181,168.06 | 18,046,198.2 | 7,898,165.87 | 10,660,297.02 |
| 其他流动负债 | 532.08 | 532.08 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 313,683,326.14 | 325,427,338.38 | 311,387,363.7 | 277,117,245.22 |
| 非流动负债: | | | | |
| 租赁负债 | 17,743,854.31 | 20,326,780.92 | 23,164,226.24 | 19,548,985.53 |
| 长期应付款 | - | - | 2,349,844 | 437,211 |
| 预计负债 | 16,219,933.8 | 15,976,526.18 | 14,106,032.89 | 13,997,649.32 |
| 递延收益 | 4,013,417.76 | 4,168,776.93 | 4,324,136.1 | 4,479,495.27 |
| 递延所得税负债 | 44,516,282.88 | 44,486,235.94 | 44,223,353.99 | 44,414,385.88 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 82,493,488.75 | 84,958,319.97 | 88,167,593.22 | 82,877,727 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 396,176,814.89 | 410,385,658.35 | 399,554,956.92 | 359,994,972.22 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 449,043,052 | 449,043,052 | 449,043,052 | 453,079,583 |
| 资本公积 | 2,748,648,181.3 | 2,748,648,181.3 | 2,748,648,181.3 | 2,744,207,003.01 |
| 减:库存股 | 48,403,712.6 | 48,403,712.6 | 48,403,712.6 | 48,403,712.6 |
| 盈余公积 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 | 25,102,306.36 |
| 未分配利润 | -1,307,215,574.97 | -1,304,237,711.58 | -1,283,886,892.67 | -1,273,125,909.3 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,867,174,252.09 | 1,870,152,115.48 | 1,890,502,934.39 | 1,900,859,270.47 |
| 少数股东权益 | 933,302.1 | 934,998.7 | 893,516.71 | 884,584.62 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,868,107,554.19 | 1,871,087,114.18 | 1,891,396,451.1 | 1,901,743,855.09 |
| 负债和股东权益合计 | 2,264,284,369.08 | 2,281,472,772.53 | 2,290,951,408.02 | 2,261,738,827.31 |
| 公告日期 | 2024-04-27 | 2024-04-13 | 2023-10-28 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |